Science Explorer Back to mapMap
Discussion
Company · Grenoble · France

Vitamib (France)

ROR OpenAlex
Research works
20
▼ 29% vs 2018-21
Citations
175
8.8 per fractional work
Top-10% rate
9.0%
all institutions 10.0%
Open access
68%
world 40%
International
37%
world 18%
Vitamib (France)

Not ranked overall: Vitamib (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vitamib (France) work in?

In all years, 52% of research at Vitamib (France) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (31%), Biochemistry, Genetics and Molecular Biology (11%), Health Professions (11%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 52.2% of its workMedicine: 6 fractional works · 30.9% of its workPathology and Forensic Medicine: 4 fractional works · 18.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 4.2% of its workGastroenterology: 0 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.7% of its workSurgery: 0 fractional works · 1.7% of its workBiochemistry: 0 fractional works · 1.5% of its workRheumatology: 0 fractional works · 0.9% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workEpidemiology: 0 fractional works · 0.3% of its workHealth Professions: 2 fractional works · 10.7% of its workGeneral Health Professions: 1 fractional works · 3.8% of its workEmergency Medical Services: 0 fractional works · 2.5% of its workPharmacy: 0 fractional works · 2.5% of its workHealth Information Management: 0 fractional works · 1.9% of its workNursing: 2 fractional works · 10.6% of its workNutrition and Dietetics: 2 fractional works · 10.6% of its workLife Sciences: 6 fractional works · 29.2% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 11.0% of its workCell Biology: 1 fractional works · 5.9% of its workMolecular Biology: 1 fractional works · 4.9% of its workGenetics: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 2 fractional works · 9.3% of its workPlant Science: 1 fractional works · 3.4% of its workAquatic Science: 0 fractional works · 2.5% of its workInsect Science: 0 fractional works · 1.3% of its workFood Science: 0 fractional works · 1.0% of its workAnimal Science and Zoology: 0 fractional works · 0.9% of its workForestry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 5.5% of its workParasitology: 0 fractional works · 2.2% of its workImmunology: 0 fractional works · 1.7% of its workMicrobiology: 0 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.4% of its workPharmacology: 1 fractional works · 3.4% of its workSocial Sciences: 2 fractional works · 10.7% of its workBusiness, Management and Accounting: 1 fractional works · 5.9% of its workMarketing: 1 fractional works · 3.4% of its workManagement Information Systems: 0 fractional works · 2.5% of its workSocial Sciences: 1 fractional works · 4.8% of its workSafety Research: 1 fractional works · 3.4% of its workHealth: 0 fractional works · 1.3% of its workEducation: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 8.0% of its workEnvironmental Science: 1 fractional works · 5.3% of its workEcology: 1 fractional works · 3.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.3% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.4% of its workEngineering: 0 fractional works · 2.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 2.5% of its workChemistry: 0 fractional works · 0.2% of its workALL ITS WORKVitamib (France)20fractional works, all years
Life Sciences29%Physical Sciences8%Health Sciences52%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine630.9%
    2. Health Professions210.7%
    3. Nursing210.6%
    1. Biochemistry, Genetics and Molecular Biology211.0%
    2. Agricultural and Biological Sciences29.3%
    3. Immunology and Microbiology15.5%
    4. Pharmacology, Toxicology and Pharmaceutics13.4%
    1. Business, Management and Accounting15.9%
    2. Social Sciences14.8%
    1. Environmental Science15.3%
    2. Engineering02.5%
    3. Chemistry00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.79× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.58× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 53.04× its world share, 1 worksPharmacology, Toxico…Engineering: 0.93× its world share, 0 worksEngineeringEnvironmental Science: 1.51× its world share, 0 worksEnvironmental ScienceMedicine: 0.08× its world share, 0 worksMedicineBusiness, Management and Accounting: 10.15× its world share, 1 worksBusiness, Management…Social Sciences: 1.48× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 53.0×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics53.04×1 works
  2. Business, Management and Accounting10.15×1 works
  3. Environmental Science1.51×0 works
  4. Social Sciences1.48×1 works
  5. Engineering0.93×0 works
  6. Agricultural and Biological Sciences0.79×0 works
  7. Biochemistry, Genetics and Molecular Biology0.58×0 works
  8. Medicine0.08×0 works

What are the most cited papers from Vitamib (France)?

The most cited paper from Vitamib (France) is "Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota–targeted dietary intervention" (James Philip Karl, Xueyan Fu, Xiaoxin Wang et al., 2015), with 53 citations. Next come "Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host" (18) and "Benefits beyond the bones - vitamin D against falls, cancer, hypertension and autoimmune diseases" (11).

Most cited papers
#PaperReleasedCitations
1 Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota–targeted dietary intervention James Philip Karl, Xueyan Fu, Xiaoxin Wang et al. · American Journal of Clinical Nutrition Open access 28 May 2015 53
2 Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host Delphine Le Roux, Vitomir Djokić, Solen Morisse et al. · Vaccine Open access 18 Dec 2019 18
3 Benefits beyond the bones - vitamin D against falls, cancer, hypertension and autoimmune diseases Hans Richard Barthel, S.H. Scharla · DMW - Deutsche Medizinische Wochenschrift Feb 2003 11
4 Medidas de radiação solar ultravioleta em Belo Horizonte e saúde pública Abel A. Silva · Brazilian Journal of Geophysics Open access Dec 2008 9
5 Estado nutricional de población vegetariana en adultos Rafael Villamayor, T Tale · Methodo Investigación Aplicada a las Ciencias Biológicas Open access 4 Apr 2023 0
All 11 most cited papers, with filters and sorting

Which research topics does Vitamib (France) publish most on?

By volume in 2022-now: Consumer Market Behavior and Pricing, Pharmaceutical industry and healthcare, Academic integrity and plagiarism and Outsourcing and Supply Chain Management.

Consumer Market Behavior and Pricing: 1 fractional worksPharmaceutical industry and healthcare: 1 fractional worksAcademic integrity and plagiarism: 1 fractional worksOutsourcing and Supply C…0Outsourcing and Supply Chain Management: 0 fractional worksMaritime Ports and Logis…0Maritime Ports and Logistics: 0 fractional worksAgriculture Sustainability and Environmental Impact: 0 fractional worksConsumer Attitudes and Food Labeling: 0 fractional worksBanana Cultivation and Research: 0 fractional worksProtein Hydrolysis and Bioactive Peptides: 0 fractional worksRural Development and Agriculture: 0 fractional works
MarketingPharmacologySafety ResearchManagement Information Systems6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Consumer Market Behavior and Pricing Marketing 1 works
  2. 2 Pharmaceutical industry and healthcare Pharmacology 1 works
  3. 3 Academic integrity and plagiarism Safety Research 1 works
  4. 4 Outsourcing and Supply Chain Management Management Information Systems 0 works
  5. 5 Maritime Ports and Logistics Industrial and Manufacturing Engineering 0 works
  6. 6 Agriculture Sustainability and Environmental Impact Ecology 0 works
  7. 7 Consumer Attitudes and Food Labeling Public Health, Environmental and Occupational Health 0 works
  8. 8 Banana Cultivation and Research Plant Science 0 works
  9. 9 Protein Hydrolysis and Bioactive Peptides Molecular Biology 0 works
  10. 10 Rural Development and Agriculture Management, Monitoring, Policy and Law 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.1%not open31.9%

World: 40% of research is openly available.

with international co-authors37.1%domestic only62.9%

World: 18% is written across borders.

How has Vitamib (France)'s research output changed?

Output in 2022-2025 was 29% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vitamib (France) as a percentage of every work published that year, 0.000011% in 2023.

still counting0.00010%0.00020%0.00030%Vitamib (France)0.000051% in 20251990200020102020

Fractional works of Vitamib (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Grenoble

All research institutions in Grenoble

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vitamib (France). Posts are plain text and can be reported.